Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-21-320838
Filing Date
2021-11-05
Accepted
2021-11-05 06:17:55
Documents
2
Period of Report
2021-11-04

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d379345d6k.htm 6-K 58421
2 GRAPHIC g379345g1104095945329.jpg GRAPHIC 7411
  Complete submission text file 0001193125-21-320838.txt   69929
Mailing Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000
Business Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-29962 | Film No.: 211382220
SIC: 2834 Pharmaceutical Preparations